LJPC Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Aug 2022 @ 16:00):

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases...

Stats
Today's Volume	960 928
Average Volume	0
Market Cap	0.00
EPS	$0.0766 ( Q2 \| 2022-08-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	47.62 (Sector) 42.63 (Industry) 24.32
ATR14	$0.137 (2.20%)

AADI -3.53%

ABCL 1.84%

ABCM 0.04%

ABEO -2.13%

ABIO -2.23%

ABOS 0.00%

ABSI 1.70%

ABUS -2.30%

ABVX -2.03%

ACAD -0.64%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.75%

ACLX 0.26%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.12%

ADGI 0.87%

ADIL 0.54%

ADMA -2.82%

ADPT -0.15%

ADTX -3.47%

ADVM -3.33%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.61%

AGEN -3.03%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.27%

AKRO -2.58%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.52%

ALEC -1.83%

ALGS -2.06%

ALKS -0.21%

ALLK -8.51%

ALLO -4.63%

ALLR -3.41%

ALNA 3.16%

ALNY 2.27%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.51%

ALVR -0.40%

ALXN 0.00%

ALXO -10.88%

ALZN 2.04%

AMRN 0.56%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.53%

ANPC -3.15%

APGE -1.09%

APGN 8.48%

APGNW 30.65%

APLM -5.01%

APLS 0.17%

APLT -3.84%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.61%

ARDS -14.23%

ARDX -0.66%

ARGX -1.04%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.40%

ARWR -1.60%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.48%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.89%

AUPH -0.99%

AURA 1.17%

AUTL -2.16%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.15%

AVTX -1.25%

AVXL -3.09%

AXLA 0.00%

AXSM -1.86%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.11%

BCAB 3.27%

BCDA -1.87%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 0.99%

BCTX 8.16%

BCTXW -17.41%

BCYC 0.50%

BDRX -4.94%

BDTX -1.06%

BEAM 0.66%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 4.92%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.25%

BMEA -11.31%

BMRN 0.51%

BNOX -2.22%

BNTC -0.42%

BNTX -1.87%

BOLD -8.58%

BOLT 0.72%

BPMC -1.25%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 25.23%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.62%

CADL -1.42%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA -0.12%

CARM 10.35%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.50%

CCCC -5.41%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.95%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 6.21%

CELC -4.58%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -1.09%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.44%

CGEN -3.87%

CGON -1.56%

CGTX -4.47%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING 2.26%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.29%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.97%

CMND 0.81%

CMPI 0.00%

CMPX -7.19%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -38.46%

CNST 0.00%

CNTA -0.51%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.76%

CORT 2.03%

COYA -1.46%

CPRX -1.22%

CRBP -3.34%

CRBU -5.10%

CRDF -1.77%

CRGX 0.47%

CRIS -0.38%

CRNX -6.15%

CRSP 1.19%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -0.86%

CTXR 2.01%

CUE 4.50%

CVAC -2.27%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 10.06%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.80%

CYTO -1.82%

DARE 6.33%

DAWN 0.37%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.54%

DNLI -1.65%

DNTH -8.21%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -3.02%

EDSA 3.19%

EFTR 3.68%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.45%

ELYM 1.26%

ENGN -4.44%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.17%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB -0.84%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.76%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX -0.17%

EXAI -0.38%

EXEL -0.31%

EYEG -0.69%

EYEN 1.45%

EYPT 0.00%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.26%

FBRX -0.04%

FDMT -4.52%

FENC -1.29%

FGEN -5.17%

FHTX 1.91%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.74%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.04%

FULC -4.01%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -1.54%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.20%

GHRS -2.16%

GLMD -2.33%

GLPG -2.27%

GLSI 1.67%

GLTO -0.57%

GLUE -2.50%

GLYC -9.70%

GMAB -0.50%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 0.00%

GNLX 0.88%

GNPX 0.98%

GNTA 3.94%

GOSS -10.05%

GOVX 4.77%

GOVXW -49.04%

GPCR -6.73%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.65%

GRTX 2.57%

GTHX 0.45%

GUTS -5.54%

GXGXW 41.67%

GYRE -7.16%

HALO -1.39%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.31%

HOOK -0.02%

HOTH -2.70%

HOWL -2.14%

HRMY 0.66%

HRTX 3.61%

HSTO 0.00%

HUMA 0.81%

HUMAW -0.01%

IBRX -4.54%

ICCC 0.22%

ICPT 0.21%

ICU 15.25%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.61%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.93%

INAB 0.00%

INBX 0.53%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 2.76%

INMB 2.60%

INO -2.34%

INSM -1.28%

INTS -2.75%

INVA 0.22%

INZY 0.68%

IOBT -11.76%

IONS 0.18%

IOVA -2.43%

IPA 2.50%

IPHA 5.58%

IPSC -2.15%

IRON -2.52%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 1.05%

JANX -4.15%

JAZZ -0.77%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.90%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.01%

KTRA 15.95%

KTTA 8.16%

KTTAW 0.92%

KURA -1.46%

KYMR -2.54%

KYTX -4.26%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.62%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.73%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.22%

LPCN -3.01%

LPTX -1.65%

LQDA -0.94%

LRMR -2.21%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.01%

LXEO -4.21%

LXRX -2.06%

LYEL -33.58%

LYRA 1.16%

MACK 0.10%

MBIO -10.60%

MBRX -2.57%

MCRB 3.01%

MDGL -3.53%

MDNA -13.16%

MDWD -0.27%

MDXG -2.80%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX 0.54%

MIRM -1.90%

MIRO 0.59%

MIST 0.76%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.50%

MLYS -7.16%

MNKD -1.34%

MNMD 0.31%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -3.34%

MREO -4.56%

MRKR 2.68%

MRNA -5.17%

MRNS -4.40%

MRSN -2.15%

MRTX -0.17%

MRUS 0.18%

MRVI -1.82%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 2.03%

NAMSW 0.43%

NAUT 1.56%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.93%

NKGN 10.62%

NKGNW 8.00%

NKTR -4.19%

NKTX -5.22%

NLSP 7.59%

NLSPW 26.67%

NMRA -2.97%

NMTR -42.97%

NOVN -24.84%

NRBO 9.15%

NRIX -0.48%

NRSN -6.31%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.71%

NTRBW -31.07%

NUVL -1.82%

NVAX -2.64%

NVCT 2.89%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.00%

OCUL -1.83%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -6.05%

OMER -0.51%

OMGA 4.56%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.42%

ORMP 21.44%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.36%

OVID -1.44%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.59%

PDSB -3.01%

PEPG 2.62%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.55%

PHIO -3.57%

PHIOW 36.47%

PHVS -6.85%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.37%

PLUR 6.01%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -10.93%

PRAX 0.37%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.37%

PRQR -0.01%

PRTA -2.74%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -7.32%

PSTX -1.16%

PTCT -0.65%

PTE -0.82%

PTGX -1.80%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -4.39%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.15%

RCKT -8.22%

REGN -0.33%

RENB -3.10%

REPL -2.95%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.28%

RLAY -4.15%

RLMD 0.33%

RLYB -0.34%

RNA -0.09%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.17%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.13%

RPTX -2.35%

RUBY 2.70%

RVLP -32.05%

RVMD -1.25%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.61%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.47%

RYTM -6.74%

RYZB 0.02%

RZLT 1.16%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -4.06%

SAVA -0.73%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -3.63%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.20%

SGMT -2.17%

SGTX -2.56%

SIOX 22.63%

SLDB -5.69%

SLGL 2.97%

SLN -4.76%

SLNO -4.21%

SLRX 6.07%

SLS -2.14%

SMMT -2.62%

SNDX 1.18%

SNGX -3.40%

SNPX -3.73%

SONN -1.08%

SPPI -0.49%

SPRB 1.52%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.30%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -5.27%

STRO -3.01%

STSA 0.00%

STTK -2.67%

SURF -0.93%

SVRA -5.14%

SWTX -0.04%

SYBX -1.94%

SYRS -1.03%

TALS -0.73%

TARA -7.98%

TARS -0.56%

TBPH 0.60%

TCBP 2.47%

TCDA 0.00%

TCON 0.68%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.16%

TENX -1.27%

TERN -7.85%

TFFP -5.21%

TGTX -3.23%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.11%

TNGX -2.76%

TNXP -4.81%

TNYA -6.83%

TPST 3.40%

TRDA -4.61%

TRVI 2.30%

TRVN 2.97%

TSHA -24.95%

TSVT -3.46%

TTNP -9.27%

TVTX 0.50%

TYRA -7.54%

UBX -2.12%

UNCY -3.90%

URGN -1.51%

UTHR -0.48%

VACC 11.36%

VALN -2.89%

VAXX 68.75%

VBIV 0.78%

VBLT -8.77%

VCEL -0.42%

VCNX 10.35%

VCYT -1.03%

VERA -3.83%

VERU -0.57%

VERV -2.96%

VIGL 7.53%

VINC 3.00%

VIR 0.76%

VIRI -1.61%

VIRX 2.40%

VKTX -1.32%

VLON -13.04%

VNDA -2.69%

VOR -2.02%

VRCA 0.00%

VRDN -4.39%

VRNA -1.66%

VRPX 0.38%

VRTX 0.32%

VSTM -2.21%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -3.85%

VYGR -0.51%

VYNE -4.35%

VYNT 7.78%

WINT -3.24%

WVE -4.50%

XBIO 0.93%

XBIT -2.70%

XCUR 3.58%

XENE -3.14%

XERS 2.14%

XFOR 2.08%

XLO 4.54%

XLRN 0.00%

XNCR 0.36%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.97%

ZNTL -0.71%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-08-22	Rosen Robert	Sell	30 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	18 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 11 680 911

Volume Correlation

Long: 0.33 (neutral)

Short: -0.74 (moderate negative)

Signal:(78.937) Neutral

La Jolla Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

La Jolla Pharmaceutical Correlation - Currency/Commodity

0.29
( neutral )

-0.63
( weak negative )

0.77
( moderate )

0.37
( neutral )

-0.47
( neutral )

-0.54
( weak negative )

La Jolla Pharmaceutical Financials

Annual	2021
Revenue:	$75.72M
Gross Profit:	$62.23M (82.19 %)
EPS:	$0.720

FY	2021
Revenue:	$75.72M
Gross Profit:	$62.23M (82.19 %)
EPS:	$0.720

FY	2020
Revenue:	$33.42M
Gross Profit:	$25.60M (76.60 %)
EPS:	$-1.440

FY	2019
Revenue:	$23.05M
Gross Profit:	$20.66M (89.62 %)
EPS:	$-4.30

Financial Reports:

No articles found.

La Jolla Pharmaceutical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

La Jolla Pharmaceutical

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.